controlled clinical studies have indicated that a single oral dose of ivermectin is safer and more effective therapy for onchocerciasis than the the standard seven- to 10-day course of diethylcarbamazine , the current drug of choice , and that ivermectin causes a more prolonged reduction in dermal microfilarial density .
C0029001
onchocerciasis
C0022322
ivermectin